Flavonoids Derived from the Roots of <i>Lespedeza bicolor</i> Inhibit the Activity of SARS-CoV Papain-like Proteaseopen access
- Authors
- Woo, Hyun Sim; Lee, Kon Ho; Park, Ki Hun; Kim, Dae Wook
- Issue Date
- Dec-2024
- Publisher
- MDPI AG
- Keywords
- SARS-CoV PLpro; <italic>Lespedeza bicolor</italic>; pterocarpan; PLpro inhibitor
- Citation
- Plants, v.13, no.23
- Indexed
- SCIE
SCOPUS
- Journal Title
- Plants
- Volume
- 13
- Number
- 23
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/75286
- DOI
- 10.3390/plants13233319
- ISSN
- 2223-7747
2223-7747
- Abstract
- Despite the now infamous coronavirus disease outbreaks caused by severe acute respiratory syndrome coronavirus (SARS-CoV), this virus continues to be a threat to the global population. Although a huge research effort has targeted SARS-CoV, no report exists regarding natural small molecules targeting one of its key enzymes, papain-like protease (PLpro). In this study, nine flavonoids displaying SARS-CoV PLpro inhibitory activity were isolated from the root bark of Lespedeza bicolor. The compounds were identified as erythrabyssin II (1), lespebuergine G4 (2), 1-methoxyerythrabyssin II (3), bicolosin A (4), bicolosin B (5), bicolosin (6), xanthoangelol (7), (+/-)-lespeol (8), and parvisoflavanone (9). Most compounds (1-4 and 6-8) inhibited SARS-CoV PLpro activity in a dose-dependent manner, with their Kis ranging from 5.56 to 75.37 mu M. The structure-activity analysis of pterocarpans (1-6) showed that activity was enhanced by C1-OCH3, but it was reduced by C8-CH3. A mechanistic analysis revealed that all inhibitors were noncompetitive. Some of the key compounds isolated in this study are pterocarpans, which are abundantly present in the Leguminosae family. Overall, a rich source of SARS-CoV papain-like protease inhibitors was identified in this study.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.